Value of Information for Clinical Trial Design: The Importance of Considering All Relevant Comparators

Ades A, Lu G, Claxton K. Expected value of sample information calculations in medical decision modelling. Med Decis Making. 2004;24:207–27.

Article  CAS  PubMed  Google Scholar 

Fenwick E, Palmer S, Claxton K, Sculpher M, Abrams K, Sutton A. An iterative Bayesian approach to health technology assessment: application to a policy of preoperative optimization for patients undergoing major elective surgery. Med Decis Making. 2006;26:480–96.

Article  PubMed  Google Scholar 

Minelli C, Baio G. Value of Information: a tool to improve research prioritization and reduce waste. PLoS Med. 2015;12(9): e1001882.

Article  PubMed  PubMed Central  Google Scholar 

Felli J, Hazen G. Sensitivity analysis and the expected value of perfect information. Med Decis Making. 1998;18:95–109.

Article  CAS  PubMed  Google Scholar 

Willan A, Pinto E. The value of information and optimal clinical trial design. Stat Med. 2005;24(12):1791–806.

Article  PubMed  Google Scholar 

McKenna C, Claxton K. Addressing adoption and research design decisions simultaneously: the role of value of sample information analysis. Med Decis Making. 2011;31(6):853–65.

Article  PubMed  Google Scholar 

Steuten L, van de Wetering G, Groothuis-Oudshoorn K, Retèl V. A systematic and critical review of the evolving methods and applications of value of information in academia and practice. Pharmacoeconomics. 2013;31(1):25–48.

Article  PubMed  Google Scholar 

Heath A, Jackson C, Kunst N. Value of information for healthcare decision-making. New York: Chapman and Hall/CRC; 2024.

Google Scholar 

Heath A, Myriam Hunink M, Krijkamp E, Pechlivanoglou P. Prioritisation and design of clinical trials. Eur J Epidemiol. 2021;36(11):1111–21.

Article  PubMed  PubMed Central  Google Scholar 

Koffijberg H, Rothery C, Chalkidou K, Grutters J. Value of information choices that influence estimates: a systematic review of prevailing considerations. Med Decis Making. 2018;38(7):888–900.

Article  PubMed  Google Scholar 

Abrahamyan L, Willan A, Beyene J, Mclimont M, Blanchette V, Feldman B. Using value-of-information methods when the disease is rare and the treatment is expensive–the example of hemophilia A. J Gen Intern Med. 2014;29(3):767–73.

Article  PubMed Central  Google Scholar 

Bennette C, Veenstra D, Basu A, Baker L, Ramsey S, Varlson J. Development and evaluation of an approach to using value of information analyses for real-time prioritization decisions within SWOG, a large cancer clinical trials cooperative group. Med Decis Making. 2016;36(5):641–51.

Article  PubMed  PubMed Central  Google Scholar 

Miquel-Cases A, Retèl A, var Harten W, Steuten L. Decisions on further research for predictive biomarkers of high-dose alkylating chemotherapy in triple-negative breast cancer: a value of information analysis. Value Health. 2016;19(4):419–20.

Article  PubMed  Google Scholar 

Neilson A, Bruhn H, Bond C, Elliott A, Smith B, Hannaford P, et al. Pharmacist-led management of chronic pain in primary care: costs and benefits in a pilot randomised controlled trial. BMJ Open. 2015;5(4):1–10.

Article  Google Scholar 

Tuffaha H, Strong M, Gordon L, Scuffham P. Efficient value of information calculation using a non-parametric regression approach: an applied perspective. Value Health. 2016;19(4):505–9.

Article  PubMed  Google Scholar 

Welton N, Madan J, Ades A. Are head-to-head trials of biologics needed? The role of value of information methods in arthritis research. Rheumatology. 2011;50(4):19–25.

Google Scholar 

Brennan A, Kharroubi S, O’Hagan A, Chilcott J. Calculating partial expected value of perfect information via Monte Carlo sampling algorithms. Med Decis Making. 2007;27:448–70.

Article  PubMed  Google Scholar 

Welton N, Madan J, Caldwell D, Peters T, Ades A. Expected Value of sampling information for multi-arm cluster randomized trials with binary outcomes. Med Decis Making. 2014;34(3):325–65.

Article  Google Scholar 

Kharroubi S, Brennan A, Strong M. Estimating expected value of sample information for incomplete data models using Bayesian approximation. Med Decis Making. 2011;31:839–52.

Article  PubMed  Google Scholar 

Jalal H, Goldhaber-Fiebert J, Kuntz K. Computing expected value of partial sample information from probabilistic sensitivity analysis using linear regression metamodeling. Med Decis Making. 2015;35(5):584–95.

Article  PubMed  PubMed Central  Google Scholar 

Menzies N. An efficient estimator for the expected value of sample information. Med Decis Making. 2016;36(3):308–20.

Article  PubMed  Google Scholar 

Strong M, Oakley J, Brennan A, Breeze P. Estimating the expected value of sample information using the probabilistic sensitivity analysis sample a fast non-parametric regression-based method. Med Decis Making. 2015;34(4):311–26.

Google Scholar 

Heath A, Manolopoulou I, Baio G. Efficient Monte Carlo estimation of the expected value of sample information using moment matching. Med Decis Making. 2018;38(2):163–73.

Article  PubMed  Google Scholar 

Brennan A, Kharroubi S. Expected value of sample information for weibull survival data. Health Econ. 2007;16(11):1205–25.

Article  PubMed  Google Scholar 

Fenwick E, Steuten L, Knies S, Ghabri S, Basu A, Murray J, et al. Value of information analysis for research decisions—an introduction: report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. Value in Health. 2020;23(2):139–50.

Article  PubMed  Google Scholar 

Rothery C, Strong M, Koffijberg H, Basu A, Ghabri S, Knies S, et al. Value of information analytical methods: report 2 of the ISPOR value of information analysis emerging good practices task force. Value Health. 2020;23(3):277–86.

Article  PubMed  PubMed Central  Google Scholar 

Jackson C, Baio G, Heath A, Strong M, Welton N, Wilson E. Value of information analysis in models to inform health policy. Ann Rev Stat Appl. 2022;9:95–118.

Article  Google Scholar 

Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies: Canada [3rd Edition]. Canadian Agency for Drugs and Technologies in Health; 2006.

Department of Health and Ageing. Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee: Version 4.3. Department of Health and Ageing; 2008.

European Network for HealthTechnology Assessment (EUnetHTA). Methods for health economic evaluations: A guideline based on current practices in Europe - second draft. EUnetHTA; 29 Sep 2014.

Lachin J. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials. 1981;2(2):93–113.

Article  CAS  PubMed  Google Scholar 

Welton N, Thom H. Value of information we’ve got speed, what more do we need? Med Decis Making. 2015;35(5):564–6.

Article  PubMed  Google Scholar 

Roberts M, Russell L, Paltiel A, Chambers M, McEwan P, Krahn M. Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force-2. Value Health. 2012;15:804–11.

Article  PubMed  PubMed Central  Google Scholar 

Sculpher M, Claxton K, Drummond M, McCabe C. Whither trial-based economic evaluation for health care? Health Econ. 2006;15:677–87.

Article  PubMed  Google Scholar 

O’Mahony J, Naber S, Normand C, Sharp L, O’Leary J, de Kok I. Beware of kinked frontiers: a systematic review of the choice of comparator strategies in cost-effectiveness analyses of human papillomavirus testing in cervical screening. Value Health. 2015;18(8):1138–51.

Article  PubMed  Google Scholar 

Jones H, Ades A, Sutton A, Welton N. Use of a random effects meta-analysis in the design and analysis of a new clinical trial. Stat Med. 2018;37(30):4665–79.

Article  PubMed  PubMed Central  Google Scholar 

Roloff V, Higgins J, Sutton A. Planning future studies based on the conditional power of a meta-analysis. Stat Med. 2013;32(1):11–24.

Article  PubMed  Google Scholar 

Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics. 2008;26(9):781–98.

Article  PubMed  Google Scholar 

Willan A, Briggs A. The statisical analysis of cost-effectiveness data. Chichester: John Wiley and Sons; 2006.

Book  Google Scholar 

Stinnett A, Mullahy J. Net health benefits a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18(2):S68–80.

Article  CAS  PubMed  Google Scholar 

National Institute for Health and Care Excellence. The guidelines manual: process and methods [PMG6]. London: National Institute for Health and Care Excellence; 2012.

Google Scholar 

Baio G. Bayesian methods in health economics. Boca Raton: CRC Press; 2012.

Book  Google Scholar 

Baio G, Dawid P. Probabilistic sensitivity analysis in health economics. Stat Methods Med Res. 2015;24(6):615–34.

Article  PubMed  Google Scholar 

Wilson E. A practical guide to value of information analysis. Pharmacoeconomics. 2015;33(2):105–21.

Article  PubMed  Google Scholar 

Conti S, Claxton K. Dimensions of design space: a decision-theoretic approach to optimal research design. Med Decis Making. 2009;29(6):643–60.

Article  PubMed  Google Scholar 

Andersson G. Epidemiological features of chronic low-back pain. The Lancet. 1999;354(9178):581–5.

留言 (0)

沒有登入
gif